HomeBIOBV • HEL
add
Biohit Oyj
Previous close
€2.50
Day range
€2.47 - €2.53
Year range
€2.35 - €3.78
Market cap
31.53M EUR
Avg Volume
591.00
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.15M | 20.59% |
Operating expense | 2.05M | 17.75% |
Net income | 900.00K | 31.58% |
Net profit margin | 21.69 | 9.10% |
Earnings per share | — | — |
EBITDA | 1.05M | 54.75% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.80M | -28.45% |
Total assets | 19.80M | 27.73% |
Total liabilities | 4.90M | 47.99% |
Total equity | 14.90M | — |
Shares outstanding | 15.20M | — |
Price to book | 2.55 | — |
Return on assets | 11.36% | — |
Return on capital | 13.64% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 900.00K | 31.58% |
Cash from operations | 300.00K | -71.24% |
Cash from investing | -200.00K | -600.00% |
Cash from financing | -100.00K | -53.85% |
Net change in cash | -200.00K | -120.26% |
Free cash flow | 512.50K | 104.34% |
About
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Founded
1988
Website
Employees
46
